Catalytic transformations of supercoiled DNA as studied by flow linear dichroism technique

被引:11
作者
Gabibov, A
Yakubovskaya, E
Lukin, M
Favorov, P
Reshetnyak, A
Monastyrsky, M
机构
[1] Russian Acad Sci, Inst Bioorgan Chem, Moscow 117871, Russia
[2] Max Planck Inst Phys Complex Syst, Dresden, Germany
[3] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia
[4] Cardiol Res Ctr, Inst Expt Cardiol, Moscow 121552, Russia
[5] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia
[6] Russian Acad Sci, Inst Theoret & Expt Phys, Moscow, Russia
关键词
anticancer drugs; flow linear dichroism; supercoiled DNA transformations; topoisomerases;
D O I
10.1111/j.1742-4658.2005.05027.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A catalytic turnover of supercoiled DNA (scDNA) transformation mediated by topoisomerases leads to changes in the linking number (Lk) of the polymeric substrate by 1 or 2 per cycle. As a substrate of the topoisomerization reaction it is chemically identical to its product; even a single catalytic event results in the quantum leap in the scDNA topology. Non-intrusive continuous assay to measure the kinetics of the scDNA topoisomerization was performed. The development of such a technique was hindered because of multiple DNA species of intermediate topology present in the reaction mixture. The interrelation of DNA topology, its hydrodynamics, and optical anisotropy enable us to use the flow linear dichroism technique (FLD) for continuous monitoring of the scDNA topoisomerization reaction. This approach permits us to study the kinetics of DNA transformation catalyzed by eukaryotic topoisomerases I and II, as well as mechanistic characteristics of these enzymes and their interactions with anticancer drugs. Moreover, FLD assay can be applied to any enzymatic reaction that involves scDNA as a substrate. It also provides a new way of screening drugs dynamically and is likely to be potent in various biomedical applications.
引用
收藏
页码:6336 / 6343
页数:8
相关论文
共 45 条
  • [1] Bis(2,6-dioxopiperazines), catalytic inhibitors of DNA topoisomerase II, as molecular probes, cardioprotectors and antitumor drugs
    Andoh, T
    [J]. BIOCHIMIE, 1998, 80 (03) : 235 - 246
  • [2] UNWINDING AND HYDRODYNAMIC FLOW LINEAR DICHROISM CHARACTERISTICS OF SUPERCOILED DNA COVALENTLY MODIFIED WITH 2 ISOMERIC METHYLCHRYSENE DIOL EPOXIDES OF DIFFERENT BIOLOGICAL-ACTIVITIES
    BALASTA, L
    XU, R
    GEACINTOV, NE
    SWENBERG, CE
    AMIN, S
    HECHT, SS
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (05) : 616 - 624
  • [3] Type II DNA topoisomerases
    Berger, JM
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (01) : 26 - 32
  • [4] STRUCTURE OF PLECTONEMICALLY SUPERCOILED DNA
    BOLES, TC
    WHITE, JH
    COZZARELLI, NR
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1990, 213 (04) : 931 - 951
  • [5] ENZYMES OF GENERAL RECOMBINATION
    COX, MM
    LEHMAN, IR
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 229 - 262
  • [6] COZZARELLI NR, 1992, P S APPL MATH, V45, P1
  • [7] LINKING NUMBERS AND NUCLEOSOMES
    CRICK, FHC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (08) : 2639 - 2643
  • [8] Favorov P V, 2000, Dokl Biochem, V370, P38
  • [9] Molecular determinants of site-specific inhibition of human DNA topoisomerase I by fagaronine and ethoxidine - Relation to DNA binding
    Fleury, F
    Sukhanova, A
    Ianoul, A
    Devy, J
    Kudelina, I
    Duval, O
    Alix, AJP
    Jardillier, JC
    Nabiev, I
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (05) : 3501 - 3509
  • [10] FRANKKAMENETSKI.MD, 1993, UNRAVELING DNA